<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39372836</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2769-2558</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PCN reports : psychiatry and clinical neurosciences</Title><ISOAbbreviation>PCN Rep</ISOAbbreviation></Journal><ArticleTitle>Greater impact of COVID-19 on peer-supported addiction services than government-owned services for addiction in Japan: A nationwide 3-year longitudinal cohort study.</ArticleTitle><Pagination><StartPage>e70012</StartPage><MedlinePgn>e70012</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70012</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/pcn5.70012</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="UNASSIGNED">This study aims to investigate how the coronavirus disease (COVID-19) pandemic impacted service provision of peer-supported addiction services, such as self-help groups or recovery houses and government-owned addiction healthcare services, in Japan, as well as the quality of their interaction.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An online survey was distributed to all 69 public regional healthcare facilities (Mental Health and Welfare Centers [MHWCs]) across the 47 prefectures of Japan annually from 2021 to 2023, totaling three surveys. The survey asked about: (1) the current status of addiction healthcare services at each center, (2) the current status of peer-supported addiction services within each center's area, and (3) changes in connectivity between centers and peer-supported addiction services.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All 69 centers participated in the survey each year. Following the second year of the pandemic, both MHWCs and peer-supported services experienced service closures and restrictions; however, peer-supported services were notably more affected nationwide, such as downsizing of services, decreased number of users, shortage of operation funds, and inability to connect with other services being widely reported (<i>p</i> &lt; 0.0001). Despite the easing of most restrictions by the fourth year, MHWCs in 18 out of 47 prefectures reported at least one sustained negative impact on their service provision, while peer-supported services struggled to recover, with 40 out of 47 prefectures still observing difficulties.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The COVID-19 pandemic significantly affected both types of service, with peer-supported services facing greater challenges in recovery. Additional support is essential to restore these services to normal operation.</AbstractText><CopyrightInformation>© 2024 The Author(s). Psychiatry and Clinical Neurosciences Reports published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katayama</LastName><ForeName>Munenori</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5614-0000</Identifier><AffiliationInfo><Affiliation>Mental Health and Welfare Center City of Yokohama Kanagawa Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Drug Dependence Research Institute of Mental Health, National Center of Neurology and Psychiatry Tokyo Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujishiro</LastName><ForeName>Sou</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aichi Prefectural Mental Health and Welfare Center Aichi Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugiura</LastName><ForeName>Kanna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mental Health and Welfare Center City of Yokohama Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konishi</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mental Health and Welfare Center City of Yokohama Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inada</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, School of Medicine Kitasato University Kanagawa Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirakawa</LastName><ForeName>Norihito</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Independent Scholar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Toshihiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Drug Dependence Research Institute of Mental Health, National Center of Neurology and Psychiatry Tokyo Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>PCN Rep</MedlineTA><NlmUniqueID>9918451287106676</NlmUniqueID><ISSNLinking>2769-2558</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Japan</Keyword><Keyword MajorTopicYN="N">addiction</Keyword><Keyword MajorTopicYN="N">addiction healthcare service</Keyword><Keyword MajorTopicYN="N">impact of COVID‐19</Keyword><Keyword MajorTopicYN="N">resource allocation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39372836</ArticleId><ArticleId IdType="pmc">PMC11450250</ArticleId><ArticleId IdType="doi">10.1002/pcn5.70012</ArticleId><ArticleId IdType="pii">PCN570012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jiang Y, Yamazawa N, Kato A, Adu‐Gyamfi B, Shaw R. Reflections on pandemic governance in Japan. In: Shaw R, Pal I, editors. Pandemic risk, response, and resilience: COVID‐19 responses in cities around the world. Amsterdam: Elsevier; 2022. p. 191–204.</Citation></Reference><Reference><Citation>Machida M, Wada K. Public health responses to COVID‐19 in Japan. Glob Health Med. 2022. Apr 30;4(2):78–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066458</ArticleId><ArticleId IdType="pubmed">35586766</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada K. The history and current state of drug abuse in Japan. Ann NY Acad Sci. 2011;1216(1):62–72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21272011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J. People's responses to the COVID‐19 pandemic during its early stages and factors affecting those responses. Humanit Soc Sci Commun. 2021. Dec 1;8(1):37.</Citation></Reference><Reference><Citation>Hayashi K, Kayano T, Anzai A, Fujimoto M, Linton N, Sasanami M, et al. Assessing public health and social measures against COVID‐19 in Japan from March to June 2021. Front Med (Lausanne). 2022. Jul 12;9:937732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9315273</ArticleId><ArticleId IdType="pubmed">35903315</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai N, Gaythorpe KAM, Bhatia S, Mangal TD, Cuomo‐Dannenburg G, Unwin HJT, et al. COVID‐19 in Japan, January–March 2020: insights from the first three months of the epidemic. BMC Infect Dis. 2022. Dec 1;22(1):493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130991</ArticleId><ArticleId IdType="pubmed">35614394</ArticleId></ArticleIdList></Reference><Reference><Citation>Muto K, Yamamoto I, Nagasu M, Tanaka M, Wada K. Japanese citizens' behavioral changes and preparedness against COVID‐19: an online survey during the early phase of the pandemic. PLoS One. 2020. Jun 1;15(6):e0234292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289361</ArticleId><ArticleId IdType="pubmed">32525881</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P, Karako T. The strategy behind Japan's response to COVID‐19 from 2020‐2021 and future challenges posed by the uncertainty of the Omicron variant in 2022. BioSci Trends. 2021;15(6):350–352.</Citation><ArticleIdList><ArticleId IdType="pubmed">34980786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmagari N. How did the Tokyo Metropolitan Government respond to COVID‐19? Glob Health Med. 2022. Apr 30;4(2):67–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066467</ArticleId><ArticleId IdType="pubmed">35586763</ArticleId></ArticleIdList></Reference><Reference><Citation>Suppasri A, Kitamura M, Tsukuda H, Boret SP, Pescaroli G, Onoda Y, et al. Perceptions of the COVID‐19 pandemic in Japan with respect to cultural, information, disaster and social issues. Prog Disaster Sci. 2021. Apr 1;10:100158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923862</ArticleId><ArticleId IdType="pubmed">34095808</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadomatsu N. Legal countermeasures against COVID‐19 in Japan: effectiveness and limits of non‐coercive measures. China‐EU Law J. 2022. Nov;8(1–2):11–32.</Citation></Reference><Reference><Citation>Borovoy A. The burdens of self‐restraint: social measures and the containment of Covid‐19 in Japan. Asia‐Pac J JPN Focus. 2022;20(19):1–40.</Citation></Reference><Reference><Citation>Ikeda K, Ide S, Takahashi‐Omoe H, Minami M, Miyata H, Kawato M, et al. Required research activities to overcome addiction problems in Japan. Taiwanese J Psychiatr. 2021;35(1):6.</Citation></Reference><Reference><Citation>Kato TA, Sartorius N, Shinfuku N. Forced social isolation due to COVID‐19 and consequent mental health problems: lessons from Hikikomori. In: Psychiatry and Clinical Neurosciences, Vol. 74. Blackwell Publishing; 2020. p. 506–507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404367</ArticleId><ArticleId IdType="pubmed">32654336</ArticleId></ArticleIdList></Reference><Reference><Citation>
McCurry J. No kissing, no sharing: can Tokyo's hostess bars survive Covid‐19? The Guardian [Internet]. 2020.  Jul 23 [cited 2024 Jul 9]. Available from: https://www.theguardian.com/world/2020/jul/23/tokyo-red-light-district-closed-coronavirus-bars-restaurants-kabukicho
</Citation></Reference><Reference><Citation>
Okutsu A. Japan struggles to shut down pachinko parlors as it battles virus. NIKKEI Asia [Internet]. 2020.  Apr 24 [cited 2024 Jul 9]. Available from: https://asia.nikkei.com/Spotlight/Coronavirus/Japan-struggles-to-shut-down-pachinko-parlors-as-it-battles-virus
</Citation></Reference><Reference><Citation>Stickley A, Shirama A, Inagawa T, Sumiyoshi T. Binge drinking in Japan during the COVID‐19 pandemic: prevalence, correlates and association with preventive behaviors. Drug Alcohol Depend. 2022. May 1;234:109415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934738</ArticleId><ArticleId IdType="pubmed">35381568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugaya N, Yamamoto T, Suzuki N, Uchiumi C. Change in alcohol use during the prolonged COVID‐19 pandemic and its psychosocial factors: a one‐year longitudinal study in Japan. Int J Environ Res Public Health. 2023. Mar 1;20(5):3871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10001235</ArticleId><ArticleId IdType="pubmed">36900880</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoshima H, Shin J, Takada D, Morishita T, Kunisawa S, Imanaka Y. The impact of the COVID‐19 epidemic on hospital admissions for alcohol‐related liver disease and pancreatitis in Japan. Sci Rep. 2021. Dec 1;11(1):14054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8275590</ArticleId><ArticleId IdType="pubmed">34253741</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto T, Usami T, Yamamoto T, Funada D, Murakami M, Okita K, et al. Impact of COVID‐19‐related stress on methamphetamine users in Japan. Psychiatry Clin Neurosci. 2021;75(7):236–238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251041</ArticleId><ArticleId IdType="pubmed">33871894</ArticleId></ArticleIdList></Reference><Reference><Citation>King DL, Achab S, Higuchi S, Bowden‐Jones H, Müller KW, Billieux J, et al. Gaming disorder and the COVID‐19 pandemic: treatment demand and service delivery challenges. J Behav Addict. 2022;11(2):243–248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295227</ArticleId><ArticleId IdType="pubmed">35413005</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama M, Sugiura K, Fujishiro S, Kobara K, Honda Y, Amano T, et al. Impact of COVID‐19 on persons with addiction and the reginal recovery‐supporting system from addiction in Japan. Psychiatr Neurol JPN. 2022;124(10):700–709.</Citation></Reference><Reference><Citation>Kumagai S, Aoyama T, Ino E, Watanabe K. Oxcgrt‐based evaluation of anti‐Covid‐19 measures taken by Japanese prefectures. J Disaster Res. 2021;16(1):16–23.</Citation></Reference><Reference><Citation>R Core Team . R: a language and environment for statistical computing.Vienna, Austria: R Foundation for Statistical Computing; 2021.</Citation></Reference><Reference><Citation>Isasi F, Naylor MD, Skorton D, Grabowski D, Hernandez S, Montgomery Rice V. Patients, families, and communities COVID‐19 impact assessment: lessons learned and compelling needs. NAM Perspect [Internet]. 2021. Nov 29;2021. 10.31478/202111c</Citation><ArticleIdList><ArticleId IdType="doi">10.31478/202111c</ArticleId><ArticleId IdType="pmc">PMC8803391</ArticleId><ArticleId IdType="pubmed">35118349</ArticleId></ArticleIdList></Reference><Reference><Citation>Schomerus G, Baumann E, Sander C, Speerforck S, Angermeyer MC. Some good news for psychiatry: resource allocation preferences of the public during the COVID‐19 pandemic. World Psychiatry. 2021. Jun 18;20(2):301–302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129839</ArticleId><ArticleId IdType="pubmed">34002529</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckwalter W, Peterson A. Public attitudes toward allocating scarce resources in the COVID‐19 pandemic. PLoS One. 2020. Nov 1;15(11 November):0240651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641460</ArticleId><ArticleId IdType="pubmed">33147213</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemberie WB, Stewart Williams J, Eriksson M, Grönlund AS, Ng N, Blom Nilsson M, et al. Substance use disorders and COVID‐19: multi‐faceted problems which require multi‐pronged solutions. Front Psychiatry. 2020. Jul 21;11:714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396653</ArticleId><ArticleId IdType="pubmed">32848907</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Monitoring Centre for Drug and Drug Addiction (EMCDDA)
. EMCDDA update on the implications of COVID‐19 for people who use drugs (PWUD) and drug service providers [Internet]. 2020.  [cited 2024 Jul 10]. Available from: https://www.euda.europa.eu/publications/topic-overviews/covid-19-and-people-who-use-drugs_en
</Citation></Reference><Reference><Citation>
Canadian Centre on Substance Use and Addiction
. Impacts of the COVID‐19 pandemic on people who use substances: what we heard [Internet]. 2020.  [cited 2024 Jul 10]. Available from: https://www.ccsa.ca/impacts-covid-19-pandemic-people-who-use-substances-what-we-heard
</Citation></Reference><Reference><Citation>Gershengorn HB. Inequitable resource allocation amidst a pandemic—a crisis within a crisis. JAMA Network Open. 2022;5(3):e221751.</Citation><ArticleIdList><ArticleId IdType="pubmed">35289866</ArticleId></ArticleIdList></Reference><Reference><Citation>Liese BS, Monley CM. Providing addiction services during a pandemic: lessons learned from COVID‐19. J Subst Abuse Treat. 2021. Jan 1;120:108156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7531327</ArticleId><ArticleId IdType="pubmed">33036878</ArticleId></ArticleIdList></Reference><Reference><Citation>Columb D, Hussain R, O'Gara C. Addiction psychiatry and COVID‐19: impact on patients and service provision. Irish J Psychol Med. 2020; 37:164–168</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280151</ArticleId><ArticleId IdType="pubmed">32434597</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed OC, de Ruiter WK, Buckley L, Selby P. Coronavirus disease 2019 and the impact on substance use disorder treatments. Psychiatr Clin North Am. 2022. Mar 1;45(1):95–107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8585604</ArticleId><ArticleId IdType="pubmed">35219445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hills HA, Lengnick‐Hall R, Johnson KA, Vermeer W, Hendricks Brown C, McGovern M. Rapid adaptation during the COVID crisis: challenges experienced in delivering service to those with opioid use disorders. Implement Res Pract. 2022. Jan;3:263348952210962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9924287</ArticleId><ArticleId IdType="pubmed">37091103</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield J, Dumbrell J, Matheson C, Parkes T, Bancroft A. The impact of COVID‐19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study. BMC Public Health. 2022. Dec 1;22(1):500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920805</ArticleId><ArticleId IdType="pubmed">35287630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hari J. Chasing the scream: the first and last days of the war on drugs. 1st ed. London: Bloomsbury Circus; 2015.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>